{"basic_info": {"ticker": "603716", "exchange": "XSHG", "bloomberg_ticker": "603716 CH Equity", "name": "THALYS MEDICAL TECHNOLOGY GR", "industry": "Biotechnology", "name_chinese_simplified": "塞力医疗", "period": "2020", "market_value": 3169712896, "total_income": 1830771616, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 1830771600, "business_income_over_total_income": 0.9999999912605155}, {"shariah_compliance": "unknown", "income": 16, "business_income_over_total_income": 8.739484412019636e-09}], "details": [{"business_activity_cn": "诊断试剂及耗材", "business_activity_en": "Diagnostic reagents and supplies", "income": 1787031000, "business_income_over_total_income": 0.9761080980184914, "shariah_compliance": "compliant"}, {"business_activity_cn": "体外诊断仪器设备", "business_activity_en": "In vitro diagnostic instruments and equipment", "income": 43740600, "business_income_over_total_income": 0.02389189324202413, "shariah_compliance": "compliant"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 16, "business_income_over_total_income": 8.739484412019636e-09, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.4921875771860394, "shariah_compliance": "non-compliant", "amount_over_market_value": 0.4921875771860394}]}